These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
647 related articles for article (PubMed ID: 28478586)
1. A Review of Autologous Stem Cell Transplantation in Lymphoma. Zahid U; Akbar F; Amaraneni A; Husnain M; Chan O; Riaz IB; McBride A; Iftikhar A; Anwer F Curr Hematol Malig Rep; 2017 Jun; 12(3):217-226. PubMed ID: 28478586 [TBL] [Abstract][Full Text] [Related]
2. Where Do the New Drugs Fit in for Relapsed/Refractory Hodgkin Lymphoma? Khan N; Moskowitz AJ Curr Hematol Malig Rep; 2017 Jun; 12(3):227-233. PubMed ID: 28488185 [TBL] [Abstract][Full Text] [Related]
3. High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group. Kasenda B; Ihorst G; Schroers R; Korfel A; Schmidt-Wolf I; Egerer G; von Baumgarten L; Röth A; Bloehdorn J; Möhle R; Binder M; Keller U; Lamprecht M; Pfreundschuh M; Valk E; Fricker H; Schorb E; Fritsch K; Finke J; Illerhaus G Leukemia; 2017 Dec; 31(12):2623-2629. PubMed ID: 28559537 [TBL] [Abstract][Full Text] [Related]
4. Y Voegeli M; Rondeau S; Berardi Vilei S; Lerch E; Wannesson L; Pabst T; Rentschler J; Bargetzi M; Jost L; Ketterer N; Bischof Delaloye A; Ghielmini M Hematol Oncol; 2017 Dec; 35(4):576-583. PubMed ID: 27677906 [TBL] [Abstract][Full Text] [Related]
5. High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma. Lahoud OB; Sauter CS; Hamlin PA; Dahi PB Curr Oncol Rep; 2015 Sep; 17(9):42. PubMed ID: 26201264 [TBL] [Abstract][Full Text] [Related]
6. New uses for brentuximab vedotin and novel antibody drug conjugates in lymphoma. Merli M; Ferrario A; Maffioli M; Olivares C; Stasia A; Arcaini L; Passamonti F Expert Rev Hematol; 2016 Aug; 9(8):767-80. PubMed ID: 27416486 [TBL] [Abstract][Full Text] [Related]
7. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas. Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Total Body Irradiation (TBI) Conditioning with Non-TBI for Autologous Stem Cell Transplantation in Newly Diagnosed or Relapsed Mature T- and NK-Cell Non-Hodgkin Lymphoma. Maeng CH; Ko YH; Lim DH; Kang ES; Choi JY; Kim WS; Kim SJ Cancer Res Treat; 2017 Jan; 49(1):92-103. PubMed ID: 27188204 [TBL] [Abstract][Full Text] [Related]
9. Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphoma. Gerrie AS; Power MM; Shepherd JD; Savage KJ; Sehn LH; Connors JM Ann Oncol; 2014 Nov; 25(11):2218-2223. PubMed ID: 25149708 [TBL] [Abstract][Full Text] [Related]
10. Iodine-131 rituximab radioimmunotherapy with BEAM conditioning and autologous stem cell transplant salvage therapy for relapsed/refractory aggressive non-Hodgkin lymphoma. Kruger PC; Cooney JP; Turner JH Cancer Biother Radiopharm; 2012 Nov; 27(9):552-60. PubMed ID: 23062193 [TBL] [Abstract][Full Text] [Related]
11. Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma. Akhtar S; Rauf SM; Elhassan TA; Maghfoor I Ann Hematol; 2016 Sep; 95(9):1521-35. PubMed ID: 27376363 [TBL] [Abstract][Full Text] [Related]
12. Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma. Kaddu-Mulindwa D; Gödel P; Kutsch N; Heger JM; Scheid C; Borchmann P; Holtick U; Held G; Thurner L; Bewarder M; Rixecker T; Bittenbring JT Clin Lymphoma Myeloma Leuk; 2022 Jul; 22(7):e498-e506. PubMed ID: 35094950 [TBL] [Abstract][Full Text] [Related]
13. [Salvage therapy in relapsed or refractory malignant lymphoma]. Kashimura T; Murohashi I Nihon Rinsho; 2000 Mar; 58(3):699-703. PubMed ID: 10741149 [TBL] [Abstract][Full Text] [Related]
14. Stem cell transplantation in Hodgkin lymphoma. Reddy NM; Perales MA Hematol Oncol Clin North Am; 2014 Dec; 28(6):1097-112. PubMed ID: 25459181 [TBL] [Abstract][Full Text] [Related]
15. DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center. Mikesch JH; Kuhlmann M; Demant A; Krug U; Thoennissen GB; Schmidt E; Kessler T; Schliemann C; Pohlen M; Mohr M; Evers G; Köhler G; Wessling J; Mesters R; Müller-Tidow C; Berdel WE; Thoennissen NH Ann Hematol; 2013 Aug; 92(8):1041-8. PubMed ID: 23532626 [TBL] [Abstract][Full Text] [Related]
16. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
17. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas. Shustov A Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643 [TBL] [Abstract][Full Text] [Related]
18. Relapsed and Refractory Classical Hodgkin Lymphoma: Keeping Pace With Novel Agents and New Options for Salvage Therapy. Moskowitz AJ; Herrera AF; Beaven AW Am Soc Clin Oncol Educ Book; 2019 Jan; 39():477-486. PubMed ID: 31099645 [TBL] [Abstract][Full Text] [Related]
19. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma. Chen CI; Roitman D; Tsang R; Stewart AK; Keating A; Crump M Bone Marrow Transplant; 2002 Dec; 30(12):885-91. PubMed ID: 12476281 [TBL] [Abstract][Full Text] [Related]
20. Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method. Gutiérrez-Aguirre CH; Ruiz-Argüelles G; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; García-Rodríguez F; López-Otero A; Herrera-Garza JL; Gómez-Almaguer D Ann Hematol; 2010 Oct; 89(10):1045-52. PubMed ID: 20490794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]